Joel Habener

Joel Habener is a Professor of Medicine at Harvard Medical School.

Habener worked with Svetlana Mojsov on elucidating the role of incretin hormones such as glucagon-like peptide-1 (GLP-1) and glucagon-like peptide-2 (GLP-2). Habener received credit for the work on hormones when Mosjov was not credited. Habener was awarded the 2020 Warren Alpert Foundation Prize along with Daniel Drucker and Jens Juul Holst. He was elected to the National Academy of Sciences in 2020. In 2021, he was awarded the Canada Gairdner International Award. In 2023, he received the VinFuture Prize. In 2024, he was awarded the Princess of Asturias Awards for Technical and Scientific Research, the Tang Prize in the category of "Biopharmaceutical Science" and also in 2024 the Lasker Award for clinical research.